Comparative evaluation of duration of post operative analgesia and block characteristics with 0.5% ropivacaine versus 0.5% levobupivacaine in axillary brachial plexus blocks for isolated upper limb injuries, a double blinded prospective clinical study.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- 2.Assessment of sensory and motor block characteristics
研究概览
简要总结
Title-Comparative evaluation of duration of post operative analgesia and block characteristics with 0.5% ropivacaine versus 0.5% levobupivacaine in axillary brachial plexus blocks for isolated upper limb injuries, a double blinded prospective clinical study.
Aims and objectives-To provide an effective method of post operative analgesia with safe drugs and reducing the need for systemic analgesics, early ambulation and less hospital stay.
Methodology and design- A prospective randomised , double- blinded study shall be conducted on 60 patients aged 20 to 65 years of either sex belonging to ASA I and ASA 2 with isolated upper limb injuries after getting informed consent. The study shall be carried out in OT complex , theater 8 of Saveetha Medical College hospital.
Pregnant and lactating women ,those with neuropathies or coagulopathies, those with known allergies to the drugs and those belonging to ASA 3 or above, aged below 20 years or above 65 years shall be excluded.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Participant and Investigator Blinded
入排标准
- 年龄范围
- 20.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •1 Isolated forearm and hand injuries.
- •2 Age group of 20 -65yrs belonging to ASA I and ASA II groups.
排除标准
- •1 Patients with known hypersensitivity to local anaesthetics, coagulopathy, infection at the site of block, peripheral neuropathy 2 Patient refusal 3 Age group below 20 and above 65 are excluded Belonging to ASA III, IV
- •Pregnant and lactating women.
结局指标
主要结局
2.Assessment of sensory and motor block characteristics
时间窗: first 24 hours
1.Duration of analgesia
时间窗: first 24 hours
次要结局
- safety of both drugs(first 24 hours)